13/05/2022
COMPARTIENDO EL CONOCIMIENTO!!!
Metaanalisis demuestra que la ecografia pulmonar es superior a la radiografía de tórax en el paciente cardiopata desconpensado...
Meta-Analysis of Point-of-Care Lung Ultrasonography Versus Chest Radiography in Adults With Symptoms of Acute Decompensated Heart Failure
Acute decompensated heart failure (ADHF) is a primary cause of older adults presenting to the emergency department with acute dyspnea. Point-of-care lung ultrasound (LUS) has shown comparable or superior diagnostic accuracy in comparison with a chest x-ray (CXR) in patients presenting with symptoms....
29/01/2022
COMPARTIENDO EL CONOCIMIENTO
Los probioticos si funcionan en COVID-19!!! Clinica y virologicamente...
Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial
(2022). Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial. Gut Microbes: Vol. 14, No. 1, 2018899.
30/11/2021
COMPARTIENDO EL CONOCIMIENTO!!!
Quedan cordialmente invitados a la CLASE MARATÓNICA Y SIMULACRO PREPARATORIO PARA EL PRIMER EXAMEN DE ADMISION A MEDICINA - UMSA!!!
✅Docente: Médico Ex-auxiliar de Docencia Medicina-UMSA con amplia experiencia docente.
✅Modalidad: Virtual. Clase magistral con diapositivas y pizarra virtual ademas de resolucion de preguntas clave del actual temario.
✅Costo: Bs.10
✅Fecha: Sábado de 4 de diciembre
💬 Informes y reservas al whatsapp 62545174.
16/09/2021
COMPARTIENDO LA INFORMACIÓN!!!
Una vez mas se demuestra que el remdesivir no sirve para COVID-19!!!
Favor de COMPARTIR!!!
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
No clinical benefit was observed from the use of remdesivir in patients who were admitted to hospital for COVID-19, were symptomatic for more than 7 days, and required oxygen support.
23/08/2021
LOS PROBIOTICOS MUESTRAN EFECTIVIDAD CONTRA COVID-19!!!
Un estudio de mas 400 pacientes hospitalizados demuestra beneficios significativos.
En el Centro Clínico de Inmunonutricion venimos utiilizando este tratamiento desde hace mucho tiempo con excelentes resultados!!!
Probiotics use is associated with improved clinical outcomes among hospitalized patients with COVID-19 - Lina Zhang, Huanqin Han, Xuan Li, Caozhen Chen, Xiaobing Xie, Guomei Su, Shicai Ye, Cuili Wang, Qing He, Fang Wang, Fang Huang, Zhaoqin Wang,...
Background and aims: Currently, there are no definitive therapies for coronavirus disease 2019 (COVID-19). Gut microbial dysbiosis has been proved to be associa...
10/01/2021
EL PROPÓLEO SI FUNCIONA EN COVID-19
Ensayo clinico aleatorizado lo confirma, a pesar de haber utilizado una dosis que a nuestro criterio es muy baja.
ESTAMOS ORGULLOSOS DE SER EL 1ER CENTRO DE BOLIVIA EN UTILIZAR PROPOLEO PARA COVID-19 DE FORMA PROFESIONAL Y CIENTIFICA DESDE ANTES DE ESTOS RESULTADOS!!!!
Efficacy of propolis as an adjunct treatment for hospitalized COVID-19 patients: a randomized, controlled clinical trial
Among candidate treatment options for COVID-19, propolis, produced by honey bees from bioactive plant exudates, has shown potential against viral targets and has demonstrated immunoregulatory properties. We conducted a randomized, controlled, open-label, single center trial, with a standardized prop...
01/01/2021
FELIZ AÑO NUEVO!!!
Miel y Nigella Sativa en COVID-19!!!
Estudio multicentrico aleatorizado controlado con placebo. Hay una luz al final de túnel...
Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multi-center placebo-controlled randomized clinical trial
BACKGROUND No definitive treatment exists for Coronavirus Disease 2019 (COVID-19). Honey and Nigella sativa (HNS) have established antiviral, antibacterial, anti-inflammatory and immunomodulatory properties. Hence, we investigated efficacy of HNS against COVID-19. wide METHODS We conducted a multice...
06/12/2020
Remdesivir, Interferon, Hidroxicloroquina y Lopinavir no tendrian beneficio significativo en COVID-19 segun los ultimos resultados del ensayo SOLIDARITY...
https://www.nejm.org/doi/full/10.1056/NEJMoa2023184
Favor de COMPARTIR!!!
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results | NEJM
Original Article from The New England Journal of Medicine — Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
09/11/2020
COMPARTIENDO EL CONOCIMIENTO!!!
ETIOPATOGENIA DE LA DIABETES TIPO 2
Mecanismos de la enfermedad, octeto ominoso, resistencia a insulina, incretinas y otros...
Favor de COMPARTIR!!!
DIABETES TIPO 2, ETIOPATOGENIA: Fisiopatología, Factores de Riesgo, patogénesis, mecanismos, causas.
Un cordial saludo en el presente video se describe la etiopatogenia de la Diabetes Tipo 2 desde la perspectiva actual (2020), incluyendo términos como el oct...
29/10/2020
COMPARTIENDO EL CONOCIMIENTO!!!
Publicado en CHEST JOURNAL, 1er gran estudio revisado de eficacia de Ivermectina en tratamiento de COVID-19!!! Inhibidor de la PAK-1.
Favor de COMPARTIR!!!
Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID-19 (ICON study)
Ivermectin treatment was associated with lower mortality during treatment of COVID-19, especially in patients with severe pulmonary involvement. Randomized controlled trials are needed to confirm these findings.